56 results
8-K
EX-99.1
NVRO
Nevro Corp
7 May 24
Nevro Reports First-Quarter 2024 Financial Results
4:11pm
. In addition to his current responsibilities, which include leading the company’s manufacturing processes and innovation, research and development … patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic innovation that has impacted
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Enters Into Cooperation Agreement With Engaged Capital
4:11pm
and developed its proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 100,000 patients
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
suffering from debilitating pain and developed its proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic innovation that has impacted
8-K
EX-99.1
2lj1h2y ava
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
8-K
EX-99.1
ydbek2
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-99.1
m3s e7q4s6
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
EX-99.1
fi4rrca5 owxemvqc
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
8-K
EX-99.1
298jt
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
8-K
EX-99.1
1ke03yxmj
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
buu8 vew9
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
8nvz7
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
dnw58z
1 Aug 22
Other Events
7:11am
8-K
EX-99.1
ui5fktleulvn89a
4 May 22
Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
w1h2p
23 Feb 22
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
12:00am
8-K
EX-99.1
vasq9vncxz7y02r16
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am